Literature DB >> 9843729

Nitric oxide relaxes human myometrium by a cGMP-independent mechanism.

K K Bradley1, I L Buxton, J E Barber, T McGaw, M E Bradley.   

Abstract

The role of intracellular guanosine 3',5'-cyclic monophosphate concentration ([cGMP]i) in nitric oxide (NO)-mediated relaxations in the uterus has become controversial. We found the NO donor S-nitroso-L-cysteine (CysNO) to potently (IC50 = 30 nM) inhibit spontaneous contractions in the nonpregnant human myometrium. CysNO treatment increased [cGMP]i significantly (P < 0.001), and this increase was blocked by the guanylyl cyclase inhibitors methylene blue (10 microM) or LY-83583 (1 microM); however, pretreatment with these guanylyl cyclase inhibitors failed to block CysNO-mediated relaxations. Intracellular cAMP concentrations were not altered by treatment of tissues with 10 microM CysNO. Incubation with the cGMP analogs 8-bromo-cGMP or beta-phenyl-1,N2-etheno-cGMP did not significantly affect spontaneous contractility. Pretreatment of tissues with charybdotoxin [a calcium-dependent potassium channel (BK) blocker] completely reversed CysNO-induced relaxations. We conclude that NO is a potent inhibitor of spontaneous contractile activity in the nonpregnant human uterus and that, although guanylyl cyclase and BK activities are increased by NO, increases in [cGMP]i are not required for NO-induced relaxations in this tissue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843729     DOI: 10.1152/ajpcell.1998.275.6.C1668

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  A role for voltage-gated, but not Ca2+-activated, K+ channels in regulating spontaneous contractile activity in myometrium from virgin and pregnant rats.

Authors:  Philip Irving Aaronson; Uzma Sarwar; Stephanie Gin; Uli Rockenbauch; Michelle Connolly; Alexandra Tillet; Sarah Watson; Bing Liu; Rachel Marie Tribe
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

Review 2.  A role of stretch-activated potassium currents in the regulation of uterine smooth muscle contraction.

Authors:  Iain L O Buxton; Nathanael Heyman; Yi-ying Wu; Scott Barnett; Craig Ulrich
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

3.  NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP.

Authors:  I L Buxton; R A Kaiser; N A Malmquist; S Tichenor
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

4.  Agonist-specific compartmentation of cGMP action in myometrium.

Authors:  Iain L O Buxton; Deanna Milton; Scott D Barnett; Stephen D Tichenor
Journal:  J Pharmacol Exp Ther       Date:  2010-07-22       Impact factor: 4.030

5.  Uterine smooth muscle S-nitrosylproteome in pregnancy.

Authors:  Craig Ulrich; David R Quillici; Kathleen Schegg; Rebekah Woolsey; Akira Nordmeier; Iain L O Buxton
Journal:  Mol Pharmacol       Date:  2011-10-25       Impact factor: 4.436

6.  Matrix metalloproteinases 2 and 9 are elevated in human preterm laboring uterine myometrium and exacerbate uterine contractility†.

Authors:  Craig C Ulrich; Veronica Arinze; Carolina Bueno Wandscheer; Christian Copley Salem; Camellia Nabati; Neda Etezadi-Amoli; Heather R Burkin
Journal:  Biol Reprod       Date:  2019-06-01       Impact factor: 4.285

Review 7.  The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.

Authors:  Scott D Barnett; Iain L O Buxton
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-04-10       Impact factor: 8.250

8.  Apamin inhibits NO-induced relaxation of the spontaneous contractile activity of the myometrium from non-pregnant women.

Authors:  Beata Modzelewska; Anna Kostrzewska; Marek Sipowicz; Tomasz Kleszczewski; Satish Batra
Journal:  Reprod Biol Endocrinol       Date:  2003-02-05       Impact factor: 5.211

9.  S-Nitrosoglutathione Reductase Underlies the Dysfunctional Relaxation to Nitric Oxide in Preterm Labor.

Authors:  Scott D Barnett; Christina R Smith; Craig C Ulrich; Josh E Baker; Iain L O Buxton
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

10.  Hiding in Plain Sight: Nebivolol Exhibits Compelling Tocolytic Properties.

Authors:  Scott D Barnett; Iain L O Buxton
Journal:  J Cell Mol Med       Date:  2018-09-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.